Dr. Kyusung Lee is Executive Vice President in charge of Contract Manufacturing Operation 1 of Samsung Biologics.detail open
Prior to joining Samsung in 2010, Dr. Lee held various leadership positions in biopharmaceutical companies in the U.S.
Dr. Lee began his career with Miller Brewing Company in 1991 as a biochemical engineer. He led the production team for Amoco BioProducts Corporation from 1992 to 1995 and was responsible for the technology transfer of a full scale biotechnology process, after which Dr. Lee moved to Merck & Co. During his tenure at Merck from 1995 to 2005, Dr. Lee participated in the design, construction, start-up, technology transfer, and commercial operation of Biologics and pharmaceutical manufacturing facilities.
From 2005 to 2010, Dr. Lee assumed responsibilities for technology transfer activities for Bristol-Myers Squibb Co.'s CMO programs.
Dr. Lee holds a doctoral degree in chemical engineering from Purdue University.
John Rim is Executive Vice President in charge of Contract Manufacturing Operations 2 comprising the newest plant within Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2018, Mr. Rim worked for Genentech/Roche in a variety of senior global leadership roles in Technical Operations, Product Development, and Research and Development in the US and Europe.
Mr. Rim has also held senior leadership roles with Astellas Pharmaceuticals in General Management, Sales & Marketing, Technical Operations, Customer Service, Business Development, and Strategic Planning.
Mr. Rim has over 30 years’ experience in the biopharmaceutical industry and began his career as a management consultant with Booz, Allen & Hamilton consulting to pharmaceutical companies in the US and Europe.
Mr. Rim holds a bachelor’s degree from Columbia University, a master’s degree from Stanford University, and an MBA from the Kellogg School of Management at Northwestern University.
Sam Machour is Senior Vice President and Chief Quality Officer in charge of Quality, Regulatory and Compliance at Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2019, Mr. Sam Machour spent more than 30 years supporting MedTech, Bioscience and Biopharmaceutical companies achieve business operational excellence and gain leadership in the areas of Research & Development, Quality, Regulatory, Operations and product Commercialization.
Mr. Machour served in a variety of positions of increased responsibility and scope and held senior and global leadership roles at Lonza, Becton Dickinson, Pfizer, J&J and Boehringer Ingelheim.
Mr. Machour holds a Master’s degree from Concordia University in Physics, is a graduate of Harvard’s General Management Program and is an Alumni of the Harvard’s Kennedy School of Government and the Harvard’s Healthcare Initiative.
Dongjoong Kim is Senior Vice President and Managing Director in charge of the Business Resources Innovation Center which includes the Finance Team, Business Innovation Team, Corporate Information Technology Team, and Global Employee Satisfaction Team.detail open
Prior to joining Samsung Biologics in 2014, Mr. Kim held various corporate planning and managerial leadership positions for Samsung Electronics.
Mr. Kim began his career with Samsung in 1988. Mr. Kim led the Corporate Management and Administration of Samsung Electronics from 2002 to 2014.
James Park is Senior Vice President and Managing Director of the Global Business Development Center responsible for BD Operations Team, BD Innovation Team and Integration & Marketing Part of Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2015, Mr. Park held various technical and operational positions, as well as business development management leadership positions in biopharmaceutical companies in the U.S.
Mr. Park began his career in 1989 with ALZA Corporation, a subsidiary of J & J, as a chemical engineer where he participated and led process and product development, technology transfer, validation and commercialization of several OROS products. He then worked in Technical & Alliance Management at Watson Pharmaceuticals. Transitioning to Merck as a Change Agent/Six Sigma Project Manager, Mr. Park then managed the Operational Excellence projects related to process improvements, cost savings and quality initiatives.
From 2004 to 2015, Mr. Park participated in and directed 100+ CMC due diligences on assets ranging from pre-clinical to commercial products, and managed Global Manufacturing & Supply BD activities including Licensing, Outsourcing and M&A at Bristol-Myers Squibb.
Mr. Park has over 25 years of experience in the biopharmaceutical and pharmaceutical industries.
James Yoon is Vice President and the Managing Director of the CC&C Center responsible for Contract, Legal & Compliance, Communication(PR), Procurement and Contract Development Services of Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2011, Mr. Yoon held various corporate planning and managerial leadership positions for Samsung Total Petrochemicals, a Joint Venture Company between Total of France and Samsung.
Mr. Yoon began his career with Samsung in 1986. Mr. Yoon led the business development and financial restructuring of Samsung General Chemicals from 1997 to 2003. Mr. Yoon managed administration for the Joint Venture, including the negotiation of major license agreement for petrochemicals production plants.
James Choi is Vice President and Chief Information Officer and head of the Global Information and Marketing Center responsible for the overall strategy, innovation, and operation of Samsung Biologics' IT systems and Global Public Relations.detail open
Prior to joining Samsung Biologics in 2014, Mr. Choi held various technology and operations leadership positions at major global healthcare and informatics corporations.
Mr. Choi began his career with Philips Healthcare in 1989 as Site Planning Manager and advanced through leadership positions in Customer Service eBusiness and Technology, Operations, and Information Systems for North America.
Mr. Choi then transitioned to the Informatics and Security industry and was CIO for a major background investigations, insurance intelligence, and commercial pre-employment screening company. Mr. Choi most recently served as CIO for Beckman Coulter’s Clinical Diagnostics and Life Sciences companies.
Mr. Choi has over 25 years of organizational and technology leadership experience in the healthcare and informatics industries.
Andy Yongsin Kim is Vice President and Managing Director of the GCS center responsible for the Global Employee Satisfaction (Overall HR duties), Information Security and Environment, Safety & Health services at Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2010, Mr. Kim was at Samsung Electronics, where he began his career in 1987, as Director of Human Resources for the Visual Display Division.
Most notably, he carried out his duties from 2004 to 2009 by establishing Samsung’s new brand presence in three countries in Eastern Europe (HU,CZ,SK), supporting sales & manufacturing, and overseeing all HR affairs.
Eun Young Yang is Vice President and Team Leader responsible for CDO Business Team and CDO Sales & Marketing of Samsung Biologics.detail open
Ms. Yang has over 20 years of experience in biopharmaceutical and pharmaceutical industries.
Ms. Yang began her career in 1997 as a Pharmacist at Seoul National University Hospital, then expanded her career into the pharmaceutial industry as a Product/Brand Manager in Sales & Markeing with global pharmaceutical companies such as Roche, Eli Lilly. Ms. Yang then continued her career as a Registered Pharmacist in the U.S, until she joined Samsung in 2011.
John Kim is Vice President and Team Leader responsible for Corporate Quality and Regulatory Affairs at Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2019, Mr. Kim held various leading positions in global pharmaceutical companies.
Mr. Kim is a pharmacist and studied law, leading to a career as a Patent Examiner for United States Patent and Trademark Office and then serving as a Regulatory Project Manager with US Food and Drug Administration from 2003 to 2008.
Transitioning to into industry as a Senior Director for Ferring Pharmaceuticals, Mr. Kim managed Regulatory Affairs.
From 2013 to 2019, Mr. Kim was in charge of Quality Assurance, Regulatory Affairs and Vigilance at Pierre Fabre USA.